,i #aaeth ,,congress #b;d ,session ,h4 ,r4 #egbe ,,in ,,the ,,house ,,of ,,representatives ,may #i1 #bjah,mr4 ,roskam 7for himself1 ,ms4 ,snchez1 ,mr4 ,shimkus1 and ,mr4 ,ruiz7 introduced the following bill2 which was referred to the ,committee on ,ways and ,means1 and in addition to the ,committee on ,energy and ,commerce1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to direct the ,secretary of ,health and ,human ,services to submit to ,congress a report on the extent to which ,medicare ,advantage plans offered under part ,c of the ,medicare program include supplemental health care benefits designed to treat or prevent substance use disorders4 #a4 ,short title ,this ,act may be cited as the ,benefit ,evaluation of ,safe ,treatment ,act of #bjah or the ,,best ,act of #bjah4 #b4 ,studying the availability of supplemental benefits designed to treat or prevent substance use disorders under ,medicare ,advantage plans 7a7 ,in general ,not later than #b years after the date of the enactment of this ,act1 the ,secretary of ,health and ,human ,services 7in this section referred to as the ,secretary7 shall submit to ,congress a report on the availability of supplemental health care benefits 7as described in section #aheb7;a77#c77;,a7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#bb7;a77#c77;,a777 designed to treat or prevent substance use disorders under ,medicare ,advantage plans offered under part ,c of title ,,xviii of such ,act4 ,such report shall include the analysis described in subsection 7c7 and any differences in the availability of such benefits under specialized ,,ma plans for special needs individuals 7as defined in section #ahei7;b77#f7 of such ,act 7#db ,u4,s4,c4 #aciew-#bh7;b77#f777 offered to individuals entitled to medical assistance under title ,,xix of such ,act and other such ,medicare ,advantage plans4 7b7 ,consultation ,the ,secretary shall develop the report described in subsection 7a7 in consultation with relevant stakeholders1 including-- 7#a7 individuals entitled to benefits under part ,a or enrolled under part ,b of title ,,xviii of the ,social ,security ,act2 7#b7 entities who advocate on behalf of such individuals2 7#c7 ,medicare ,advantage organizations2 7#d7 pharmacy benefit managers2 and 7#e7 providers of services and suppliers 7as such terms are defined in section #ahfa of such ,act 7#db ,u4,s4,c4 #aciex774 7c7 ,contents ,the report described in subsection 7a7 shall include an analysis on the following3 7#a7 ,the extent to which plans described in such subsection offer supplemental health care benefits relating to coverage of-- 7,a7 medication-assisted treatments for opioid use1 substance use disorder counseling1 peer recovery support services1 or other forms of substance use disorder treatments 7whether furnished in an inpatient or outpatient setting72 and 7,b7 non-opioid alternatives for the treatment of pain4 7#b7 ,challenges associated with such plans offering supplemental health care benefits relating to coverage of items and services described in subparagraph 7,a7 or 7,b7 of paragraph 7#a74 7#c7 ,the impact1 if any1 increasing the applicable rebate percentage determined under section #ahed7;b77#a77;,c7 of the ,social ,security ,act 7#db ,u4,s4,c4 #aciew-#bd7;b77#a77;,c77 for plans offering such benefits relating to such coverage would have on the availability of such benefits relating to such coverage offered under ,medicare ,advantage plans4 7#d7 ,potential ways to improve upon such coverage or to incentivize such plans to offer additional supplemental health care benefits relating to such coverage4